Merck & Co., Inc. (NYSE: MRK) reported Q1 EPS of $0.99, $0.02 better than the analyst estimate of $0.97. Revenue for the quarter came in at $11.73 billion versus the consensus estimate of $11.82 billion.

Merck & Co., Inc. reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.

Earnings Guidance